vs
Esperion Therapeutics, Inc.（ESPR）与Ranpak Holdings Corp.（PACK）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Ranpak Holdings Corp.的1.8倍（$168.4M vs $93.7M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 2.3%），过去两年Ranpak Holdings Corp.的营收复合增速更高（13.7% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Ranpak Holdings Corp.主营生产防护纸质包装设备与纸制品，可为电商及各行业货品运输提供纸质缓冲包装方案，同时也供应自动化包装解决方案。公司总部位于美国俄亥俄州康科德，在美国本土多个州、捷克、荷兰、中国上海及新加坡均设有生产基地与办公室，产品可用于包裹缠绕、缓冲填隙、冷链运输等多种场景。
ESPR vs PACK — 直观对比
营收规模更大
ESPR
是对方的1.8倍
$93.7M
营收增速更快
ESPR
高出141.4%
2.3%
两年增速更快
PACK
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $93.7M |
| 净利润 | — | — |
| 毛利率 | — | 39.0% |
| 营业利润率 | 50.6% | -1.0% |
| 净利率 | — | — |
| 营收同比 | 143.7% | 2.3% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRPACK
| Q4 25 | $168.4M | $93.7M | ||
| Q3 25 | $87.3M | $83.6M | ||
| Q2 25 | $82.4M | $77.8M | ||
| Q1 25 | $65.0M | $77.6M | ||
| Q4 24 | $69.1M | $91.6M | ||
| Q3 24 | $51.6M | $78.6M | ||
| Q2 24 | $73.8M | $72.8M | ||
| Q1 24 | $137.7M | $72.5M |
净利润ESPRPACK
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-10.4M | ||
| Q2 25 | $-12.7M | $-7.5M | ||
| Q1 25 | $-40.5M | $-10.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-8.1M | ||
| Q2 24 | $-61.9M | $5.5M | ||
| Q1 24 | $61.0M | $-8.1M |
毛利率ESPRPACK
| Q4 25 | — | 39.0% | ||
| Q3 25 | — | 41.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 39.8% | ||
| Q4 24 | — | 45.2% | ||
| Q3 24 | — | 43.8% | ||
| Q2 24 | — | 43.5% | ||
| Q1 24 | — | 44.6% |
营业利润率ESPRPACK
| Q4 25 | 50.6% | -1.0% | ||
| Q3 25 | -11.4% | -6.8% | ||
| Q2 25 | 8.6% | -12.5% | ||
| Q1 25 | -34.0% | -10.3% | ||
| Q4 24 | -6.4% | 1.5% | ||
| Q3 24 | -31.0% | -5.3% | ||
| Q2 24 | 3.5% | -7.1% | ||
| Q1 24 | 52.5% | -6.6% |
净利率ESPRPACK
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -12.4% | ||
| Q2 25 | -15.4% | -9.6% | ||
| Q1 25 | -62.2% | -14.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -10.3% | ||
| Q2 24 | -83.9% | 7.6% | ||
| Q1 24 | 44.3% | -11.2% |
每股收益（稀释后）ESPRPACK
| Q4 25 | $0.32 | $-0.11 | ||
| Q3 25 | $-0.16 | $-0.12 | ||
| Q2 25 | $-0.06 | $-0.09 | ||
| Q1 25 | $-0.21 | $-0.13 | ||
| Q4 24 | $-0.14 | $-0.13 | ||
| Q3 24 | $-0.15 | $-0.10 | ||
| Q2 24 | $-0.33 | $0.07 | ||
| Q1 24 | $0.34 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $63.0M |
| 总债务越低越好 | — | $401.9M |
| 股东权益账面价值 | $-302.0M | $534.9M |
| 总资产 | $465.9M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.75× |
8季度趋势，按日历期对齐
现金及短期投资ESPRPACK
| Q4 25 | $167.9M | $63.0M | ||
| Q3 25 | $92.4M | $49.9M | ||
| Q2 25 | $86.1M | $49.2M | ||
| Q1 25 | $114.6M | $65.5M | ||
| Q4 24 | $144.8M | $76.1M | ||
| Q3 24 | $144.7M | $69.5M | ||
| Q2 24 | $189.3M | $65.1M | ||
| Q1 24 | $226.6M | $55.1M |
总债务ESPRPACK
| Q4 25 | — | $401.9M | ||
| Q3 25 | — | $403.1M | ||
| Q2 25 | — | $403.1M | ||
| Q1 25 | — | $405.2M | ||
| Q4 24 | — | $406.4M | ||
| Q3 24 | — | $403.2M | ||
| Q2 24 | — | $396.1M | ||
| Q1 24 | — | $396.7M |
股东权益ESPRPACK
| Q4 25 | $-302.0M | $534.9M | ||
| Q3 25 | $-451.4M | $537.8M | ||
| Q2 25 | $-433.5M | $539.0M | ||
| Q1 25 | $-426.2M | $544.1M | ||
| Q4 24 | $-388.7M | $548.1M | ||
| Q3 24 | $-370.2M | $564.3M | ||
| Q2 24 | $-344.2M | $566.2M | ||
| Q1 24 | $-294.3M | $560.0M |
总资产ESPRPACK
| Q4 25 | $465.9M | $1.1B | ||
| Q3 25 | $364.0M | $1.1B | ||
| Q2 25 | $347.1M | $1.1B | ||
| Q1 25 | $324.0M | $1.1B | ||
| Q4 24 | $343.8M | $1.1B | ||
| Q3 24 | $314.1M | $1.1B | ||
| Q2 24 | $352.3M | $1.1B | ||
| Q1 24 | $373.1M | $1.1B |
负债/权益比ESPRPACK
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.74× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.71× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.71× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $19.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRPACK
| Q4 25 | $45.2M | $19.5M | ||
| Q3 25 | $-4.3M | $8.5M | ||
| Q2 25 | $-31.4M | $-3.6M | ||
| Q1 25 | $-22.6M | $-1.3M | ||
| Q4 24 | $-35.0M | $6.5M | ||
| Q3 24 | $-35.3M | $10.1M | ||
| Q2 24 | $-7.2M | $19.6M | ||
| Q1 24 | $53.8M | $5.2M |
自由现金流ESPRPACK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
自由现金流率ESPRPACK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
资本支出强度ESPRPACK
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ESPRPACK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.56× | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
PACK
| Other | $47.9M | 51% |
| Europe And Asia Segment | $45.8M | 49% |
